Literature DB >> 22895713

Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons.

Xiqun Chen1, Patricia Tagliaferro, Tatyana Kareva, Olga Yarygina, Nikolai Kholodilov, Robert E Burke.   

Abstract

Mesencephalic dopamine neurons are central to many aspects of human cognition, motivational, and motor behavior, and they are uniquely vulnerable to degenerative neurologic disorders such as Parkinson's disease. There is growing evidence that in the mature brain these neurons not only remain responsive to neurotrophic support, but are dependent on it for viability and function. Little is known of the cellular signaling pathways that mediate this support, although some evidence suggests that protein kinase Akt/PKB may play such a role. Another candidate for such a role is serum- and glucocorticoid-inducible kinase (SGK), a member of the AGC kinase family that is closely related to Akt. We have herein examined the responsiveness of adult mouse dopamine neurons in vivo to overexpression of wild-type and a constitutively active form of SGK by use of viral vector transfer in normal mice and both before and after 6-OHDA lesion. We find that SGK induces a broad spectrum of neurotrophic effects on these neurons, including induction of neuronal hypertrophy, protection from both neuron death and neurotoxin-induced retrograde axonal degeneration, and axon regeneration. Given the diverse and robust effects of SGK on these neurons, and its abundant expression in them, we suggest that SGK, like closely related Akt, may play a role in their responsiveness to neurotrophic factors and in adult maintenance. It therefore offers a novel target for therapeutic development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895713      PMCID: PMC3433399          DOI: 10.1523/JNEUROSCI.5910-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

Review 1.  Wallerian degeneration, wld(s), and nmnat.

Authors:  Michael P Coleman; Marc R Freeman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

2.  Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase B.

Authors:  Vincent Ries; Hsiao-Chun Cheng; Amy Baohan; Tatyana Kareva; Tinmarla F Oo; Margarita Rzhetskaya; Ross J Bland; Matthew J During; Nikolai Kholodilov; Robert E Burke
Journal:  J Neurochem       Date:  2009-04-16       Impact factor: 5.372

Review 3.  The nuts and bolts of AGC protein kinases.

Authors:  Laura R Pearce; David Komander; Dario R Alessi
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

Review 4.  Molecules, signaling, and schizophrenia.

Authors:  Mirna Kvajo; Heather McKellar; Joseph A Gogos
Journal:  Curr Top Behav Neurosci       Date:  2010

5.  Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling.

Authors:  Sang Ryong Kim; Vincent Ries; Hsiao-Chun Cheng; Tatyana Kareva; Tinmarla F Oo; W Haung Yu; Karen Duff; Nikolai Kholodilov; Robert E Burke
Journal:  Neurobiol Dis       Date:  2011-07-18       Impact factor: 5.996

6.  Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy.

Authors:  Hsiao-Chun Cheng; Sang Ryong Kim; Tinmarla F Oo; Tatyana Kareva; Olga Yarygina; Margarita Rzhetskaya; Chuansong Wang; Matthew During; Zsolt Talloczy; Keiji Tanaka; Masaaki Komatsu; Kazuto Kobayashi; Hideyuki Okano; Nikolai Kholodilov; Robert E Burke
Journal:  J Neurosci       Date:  2011-02-09       Impact factor: 6.167

7.  Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration.

Authors:  Sang Ryong Kim; Xiqun Chen; Tinmarla F Oo; Tatyana Kareva; Olga Yarygina; Chuansong Wang; Matthew During; Nikolai Kholodilov; Robert E Burke
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

8.  DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway.

Authors:  Hossein Aleyasin; Maxime W C Rousseaux; Paul C Marcogliese; Sarah J Hewitt; Isabella Irrcher; Alvin P Joselin; Mohammad Parsanejad; Raymond H Kim; Patrizia Rizzu; Steve M Callaghan; Ruth S Slack; Tak W Mak; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

Review 9.  mTOR signaling: at the crossroads of plasticity, memory and disease.

Authors:  Charles A Hoeffer; Eric Klann
Journal:  Trends Neurosci       Date:  2009-12-04       Impact factor: 13.837

10.  New insights into mTOR signaling: mTORC2 and beyond.

Authors:  Dario R Alessi; Laura R Pearce; Juan M García-Martínez
Journal:  Sci Signal       Date:  2009-04-21       Impact factor: 8.192

View more
  8 in total

1.  Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Authors:  Pablo Villoslada; Gemma Vila; Valeria Colafrancesco; Beatriz Moreno; Begoña Fernandez-Diez; Raquel Vazquez; Inna Pertsovskaya; Irati Zubizarreta; Irene Pulido-Valdeolivas; Joaquin Messeguer; Gloria Vendrell-Navarro; Jose Maria Frade; Noelia López-Sánchez; Meritxell Teixido; Ernest Giralt; Mar Masso; Jason C Dugas; Dmitri Leonoudakis; Karen D Lariosa-Willingham; Lawrence Steinman; Angel Messeguer
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

2.  Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling Pathway.

Authors:  Sarah Iqbal; Shannon Howard; Philip V LoGrasso
Journal:  Mol Cell Biol       Date:  2015-03-30       Impact factor: 4.272

3.  Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson disease.

Authors:  Xiaotian Sun; Pascaline Aimé; David Dai; Nagendran Ramalingam; John F Crary; Robert E Burke; Lloyd A Greene; Oren A Levy
Journal:  Exp Neurol       Date:  2018-02-09       Impact factor: 5.330

4.  Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.

Authors:  Jordi Creus-Muncunill; Laura Rué; Rafael Alcalá-Vida; Raquel Badillos-Rodríguez; Joan Romaní-Aumedes; Sonia Marco; Jordi Alberch; Isabel Perez-Otaño; Cristina Malagelada; Esther Pérez-Navarro
Journal:  Mol Neurobiol       Date:  2018-02-19       Impact factor: 5.590

5.  Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference.

Authors:  Qing-Rong Liu; Ana Canseco-Alba; Hai-Ying Zhang; Patricia Tagliaferro; Monika Chung; Eugene Dennis; Branden Sanabria; Norman Schanz; Joao Carlos Escosteguy-Neto; Hiroki Ishiguro; Zhicheng Lin; Susan Sgro; Claire M Leonard; Jair Guilherme Santos-Junior; Eliot L Gardner; Josephine M Egan; Jeung Woon Lee; Zheng-Xiong Xi; Emmanuel S Onaivi
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

6.  Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1.

Authors:  Edward J Robinson; Sebastian P Aguiar; Willemieke M Kouwenhoven; Dorinde S Starmans; Lars von Oerthel; Marten P Smidt; Lars P van der Heide
Journal:  Cell Death Discov       Date:  2018-11-21

7.  Induction of the cell survival kinase Sgk1: A possible novel mechanism for α-phenyl-N-tert-butyl nitrone in experimental stroke.

Authors:  Catherine McCaig; Paris Ataliotis; Anan Shtaya; Ayan S Omar; A Richard Green; Clive N Kind; Anthony C Pereira; Aniko Naray-Fejes-Toth; Geza Fejes-Toth; Rafael J Yáñez-Muñoz; James T Murray; Atticus H Hainsworth
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-20       Impact factor: 6.200

8.  The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease.

Authors:  Pascaline Aimé; Saravanan S Karuppagounder; Apeksha Rao; Yingxin Chen; Robert E Burke; Rajiv R Ratan; Lloyd A Greene
Journal:  Neurobiol Dis       Date:  2020-01-03       Impact factor: 5.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.